Harold F. Dvorak
Beth Israel Deaconess Medical Center
351 Papers
7.3K Citations
Harold F. Dvorak is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Angiogenesis & Vascular endothelial growth factor. The author has an hindex of 117, co-authored 351 publications. Previous affiliations of Harold F. Dvorak include Harvard University & Benaroya Research Institute.
Chat about Author
Papers
Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response.
TL;DR: It is reported that widespread microvascular damage is a characteristic, early consequence of the cellular immune response to first-set human skin allografts and is qualitatively similar to, but substantially more extensive than, that occurring in delayed hypersensitivity reactions.
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.
Anthony J. Guidi,Graziella Abu-Jawdeh,Kathi Tognazzi,Harold F. Dvorak,Lawrence F. Brown,Lawrence F. Brown +5 more
TL;DR: Vascular permeability factor (VPF), also known as vascular endothelial growth factor (VEGF), is a multifunctional cytokine that is an important regulator of tumor angiogenesis.
144
•Journal Article
The Late Phase Skin Reaction: Evidence for Activation of the Coagulation System in an IgE-Dependent Reaction in Man
TL;DR: The failure of RW-H injection to induce LPR argues against a gatekeeper role for WFR in the genesis of LPR and suggests that LPR may follow small RW doses, suggesting activation of the coagulation system in these IgE-dependent “delayed in time” reactions.
139
•Journal Article
Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
TL;DR: The strong expression of both KDR and flt-1 in small stromal vessels in and around tumors suggests that VPF/VEGF may be an important regulator of the edema and angiogenesis seen in these tumors.
134